James F Emigh Acura Pharmaceuticals, Inc (ACUR) insider trading activity

ACUR Quotes by TradingView

James F Emigh is VP, Corporate Development of ACURA PHARMACEUTICALS, INC. Currently has a direct ownership of 474,042 shares of ACUR, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2021, when has been sold 7,550 shares (Common Stock) at a price of $0.4 per share, resulting in proceeds of $3,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 474K
0% 3M change
0% 12M change
Total Value Held $0

JAMES F EMIGH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2021
SELL
Payment of exercise price or tax liability
$3,020 $0.4 p/Share
7,550 Reduced 1.57%
474,042 Common Stock
Feb 24 2021
BUY
Exercise of conversion of derivative security
$3,000 $0.15 p/Share
20,000 Added 3.99%
481,592 Common Stock
Jan 04 2021
SELL
Payment of exercise price or tax liability
$1,554 $0.21 p/Share
7,402 Reduced 1.58%
461,592 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
-
24,667 Added 5.0%
468,994 Common Stock
JFE

James F Emigh

VP, Corporate Development
Palatine, IL

Track Institutional and Insider Activities on ACUR

Follow ACURA PHARMACEUTICALS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACUR shares.

Notify only if

Insider Trading

Get notified when an Acura Pharmaceuticals, Inc insider buys or sells ACUR shares.

Notify only if

News

Receive news related to ACURA PHARMACEUTICALS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACUR